Corporate Businesses

Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021

HELSINKI,  Nanoform Finland Plc (“Nanoform“), an innovative nanoparticle medicine enabling company, will publish its year-end report for 2020 on February 26, 2021, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time.

The company will hold a conference call and an online presentation on the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time. Nanoform will be represented by CEO Edward Hæggström, CFO Albert Hæggström and CCO Christian Jones. The presentation will be delivered in English.

The presentation will be broadcast live as a webcast available at: https://financialhearings.com/event/13593

Teleconference dial-in numbers:

Finland: +358 9 817 10520

Sweden: +46 8 566 42706

United Kingdom: +44 3333 009261

United States: +1 833 249 8403

About Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on Invitation reducing clinical attrition and Invitation on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806. For more information please visit http://www.nanoform.com

Nanoform is an innovative nanoparticle medicine enabling company that supplies best in class nanoforming services. Our multi-patented CESS® technology can double the amount of lead compounds progressing into clinic, leading to a significant increase in the number of drugs that reach the market. The green particle engineering process produces pure and stable nanoparticles as small as 10 nm using supercritical carbon dioxide.LEARN MORE

This news is conveyed to Prattle Prattle News through a presss release

By PR Newswire

Also read madhuri and additional

Related Posts

1 of 64